6.1 Inventory Management, Ordering & Stock Rotation (FIFO)

Inventory Management, Ordering & Stock Rotation (FIFO)

Exam Tip: Inventory control in Canadian pharmacy practice balances clinical availability against financial and operational risks. Registered Pharmacy Technicians carry primary operational responsibility for inventory maintenance, electronic ordering, stock rotation, and shortage management. On the PEBC Qualifying Examination, candidates are evaluated on calculating reorder points, applying stock rotation rules, differentiating generic from therapeutic substitution, and executing drug shortage protocols.

---

Principles of Pharmacy Inventory Management

Inventory represents the largest physical asset and operational expense in both community and institutional pharmacies. Effective inventory management ensures that life-sustaining medications are consistently available for patient care while minimizing capital tied up in carrying costs, expired product waste, and storage overhead.

Financial and Operational Metrics

1. Inventory Turnover Rate (ITR):
   • Measures how many times pharmacy inventory is sold and replaced over a specified period (typically one calendar year).
   • Calculated as: $\text{Inventory Turnover Rate} = \frac{\text{Cost of Goods Sold (COGS)}}{\text{Average Inventory Value}}$
   • A high turnover rate indicates efficient cash flow, reduced carrying costs, and lower risk of product expiration on shelves. Conversely, an excessively high turnover rate may increase the frequency of out-of-stock events (stockouts), compromising patient access.
2. Carrying Costs (Holding Costs):
   • Expenses associated with storing and maintaining unsold pharmaceuticals. These include capital financing costs, specialized refrigeration energy, automated dispensing cabinet leasing, insurance, shrinkage, and financial losses from product obsolescence or expiration.
3. Stockout Costs:
   • The clinical and operational consequences of exhausting inventory for critical therapies. In hospital practice, a stockout of norepinephrine, alteplase, or broad-spectrum antimicrobials can cause immediate patient harm, emergency transfers, and costly expedited courier deliveries.

---

Replenishment Systems: PAR Levels, ROP, and Safety Stock

Modern pharmacies utilize perpetual inventory systems embedded within Pharmacy Management Software (PMS) and automated dispensing cabinets (ADCs) to manage replenishment through automated mathematical parameters.

┌────────────────────────────────────────────────────────┐
│         Automated Inventory Replenishment Cycle         │
└────────────────────────────────────────────────────────┘
                           │
                           ▼
        ┌──────────────────────────────────────┐
        │ Periodic Automatic Replenishment     │
        │ (PAR Level Target: e.g., 50 vials)   │
        └──────────────────────────────────────┘
                           │  Continuous Dispensing
                           ▼
        ┌──────────────────────────────────────┐
        │ Reorder Point Trigger (ROP)          │
        │ (Usage during Lead Time + Safety)    │
        └──────────────────────────────────────┘
                           │  Threshold Breached
                           ▼
        ┌──────────────────────────────────────┐
        │ Electronic Order Generation (EDI)    │
        │ Order Qty = PAR Level - Current Stock │
        └──────────────────────────────────────┘
                           │  Vendor Fulfilment
                           ▼
        ┌──────────────────────────────────────┐
        │ Wholesaler Delivery & Check-in       │
        │ Restock via FIFO/FEFO Rotation       │
        └──────────────────────────────────────┘

1. Periodic Automatic Replenishment (PAR)

• PAR Level: The predetermined maximum target quantity of an item that should be maintained on site to meet routine patient demand between standard delivery cycles.
• When physical stock falls to or below a specified threshold, the software generates an automatic purchase order to bring inventory back to the PAR level: $$\text{Order Quantity} = \text{PAR Level} - \text{Current On-Hand Quantity}$$

2. Reorder Point (ROP)

• The specific inventory level that triggers a purchase order. It accounts for the rate of drug consumption during the time required for a replacement shipment to arrive.
• Lead Time: The time interval (in hours or days) between transmitting an electronic purchase order to a wholesaler and receiving, verifying, and stocking the shipment on pharmacy shelves.
• Safety Stock (Buffer Stock): A reserve quantity held to mitigate unexpected spikes in clinical demand or vendor delivery delays.
• Mathematical Model: $$\text{Reorder Point (ROP)} = (\text{Average Daily Usage} \times \text{Lead Time}) + \text{Safety Stock}$$

Practical Calculation Scenario

A tertiary care hospital pharmacy dispenses an average of 12 vials of piperacillin-tazobactam 4.5 g injection per day. The prime wholesaler provides daily deliveries with a lead time of 2 days. To guard against unexpected trauma admissions or delivery disruptions, the pharmacy maintains a safety stock of 10 vials. The established PAR level for this item is 60 vials.

$$\text{ROP} = (12 \text{ vials/day} \times 2 \text{ days}) + 10 \text{ vials} = 24 + 10 = 34 \text{ vials}$$

If the morning cycle count reveals 28 vials in active stock, the inventory has dropped below the ROP of 34 vials. The automated system generates a purchase order for:

$$\text{Order Quantity} = 60 \text{ (PAR)} - 28 \text{ (Current)} = 32 \text{ vials}$$

---

Stock Rotation & Shelf Placement: FIFO vs. FEFO

To prevent medications from expiring on dispensary shelves, pharmacy technicians must rigorously execute standardized stock rotation protocols during every receiving and stocking cycle.

Physical Stocking Mechanics

• Never place newly arrived stock in front of existing stock. Technicians must physically reach into the dispensary shelf or automated dispensing cabinet bin, move existing containers forward, and place new arrivals behind them.
• Lot Number and Expiry Verification: Verify that the expiration date of new deliveries is further in the future than that of the units already on the shelf. In situations where a newly arrived batch has an earlier expiration date than existing stock (due to wholesaler batch rotations), FEFO dictates that the newly arrived, shorter-dated product must be placed at the front.

Short-Dated Medication Monitoring Protocols

• Definition of Short-Dated Stock: Medications approaching their printed expiration date within a 3- to 6-month operational window (or facility-defined policy threshold).
• Visual Identification: Pharmacies utilize colored auxiliary dot stickers (e.g., green for expiring in 6 months, yellow for 3 months, red for current month) placed on the manufacturer bottle cap or carton shoulder.
• Monthly Expiration Audits: Technicians perform designated physical shelf sweeps on the first business day of each month, pulling products scheduled to expire during that month.
• Segregation of Expired Stock: Expired pharmaceuticals must be immediately removed from active dispensing shelves and quarantined in a designated, physically segregated, and clearly labeled non-dispensing holding bin ("EXPIRED MEDICATIONS — NOT FOR DISPENSING") to prevent accidental dispensing to patients.

---

Canadian Formularies & Institutional Governance

A formulary is an approved list of pharmaceuticals available for use within a specific healthcare facility, jurisdiction, or insurance program.

Open vs. Closed Formularies

• Open Formulary: Allows coverage or dispensing of virtually all Health Canada-approved drugs, though non-preferred agents may require patient copayments or cost-sharing. Common in private commercial insurance plans and select community retail settings.
• Closed Formulary: Strictly limits dispensing to medications officially evaluated and listed. Prescriptions for non-formulary agents are not stocked or reimbursed unless an official exception or non-formulary approval is granted. Standard in Canadian hospitals and provincial cancer agencies.

The Pharmacy and Therapeutics (P&T) Committee

• In Canadian hospital networks, the P&T Committee is a multidisciplinary advisory body composed of pharmacists, physicians, pharmacy technicians, nurses, and hospital administrators.
• Responsibilities: Evaluates clinical efficacy, safety profiles, cost-effectiveness, and budget impact before approving additions, deletions, or restrictions to the institutional formulary.
• Establishes clinical practice guidelines, automatic dose substitution protocols, and therapeutic interchange policies.

Generic vs. Therapeutic Substitution in Canada

┌────────────────────────────────────────────────────────┐
│         Canadian Substitution Decision Matrix          │
├──────────────────────────┬─────────────────────────────┤
│ Generic Substitution     │ Therapeutic Substitution    │
├──────────────────────────┼─────────────────────────────┤
│ Identical active drug    │ Chemically different drug   │
│ Identical strength/form  │ Same therapeutic class      │
│ Bioequivalent (NOC)      │ P&T / MAC pre-approved      │
│ e.g., Lipitor 20 mg ──►  │ e.g., Pantoprazole 40 mg ──►│
│ Atorvastatin 20 mg       │ Omeprazole 20 mg (inpt)     │
└──────────────────────────┴─────────────────────────────┘

1. Generic Substitution (Interchangeability):
   • Dispensing an interchangeable generic product containing the identical active chemical ingredient, dosage form, strength, and route of administration as the prescribed brand-name drug.
   • Bioequivalence Standard: In Canada, generic manufacturers must demonstrate bioequivalence through pharmacokinetic studies submitted to Health Canada. Upon establishing that the rate and extent of absorption fall within strict statistical confidence intervals (typically 80% to 125% of the reference product), Health Canada issues a Notice of Compliance (NOC).
   • Provincial pharmacy legislation and comparative drug formularies (e.g., the Ontario Drug Benefit Formulary / Comparative Drug Index) govern whether a technician or pharmacist may automatically substitute a generic product without contacting the prescriber, provided the prescriber has not written "No Substitution" or "Do Not Substitute."
2. Therapeutic Substitution (Therapeutic Interchange):
   • Dispensing a chemically distinct medication within the same therapeutic or pharmacological class that is expected to produce essentially equivalent clinical outcomes (e.g., substituting institutional formulary pantoprazole 40 mg for out-of-hospital omeprazole 20 mg, or substituting amlodipine for felodipine).
   • Legal Mandate in Canada: In community pharmacy, therapeutic substitution without prescriber consultation is unauthorized and illegal unless specific provincial collaborative practice frameworks or minor ailment regulations permit it.
   • In hospital settings, therapeutic substitution is lawful only when authorized by institutional Medical Advisory Committee (MAC) and P&T Committee pre-approved medical directives or automatic interchange policies.

---

Wholesaler Purchasing & Canadian Drug Shortages

Canadian pharmacies procure inventory through direct manufacturer contracts or prime vendor agreements with national pharmaceutical distributors (such as McKesson Canada, Cencora/AmerisourceBergen, and Kohl & Frisch).

Wholesaler Ordering & Electronic Data Interchange (EDI)

• Technicians transmit daily electronic orders via PMS integrated with EDI protocols.
• Order Cut-Off Times: Daily purchase orders must be transmitted by strict deadlines (e.g., 17:00) to ensure next-morning delivery.
• Discrepancy Reconciliation: Upon receiving wholesaler totes, technicians cross-reference packing slips against physical contents, verifying lot numbers, DINs, container integrity, and short-dated alerts before updating electronic inventory ledgers.

Managing Canadian Drug Shortages

• Reporting Mandate: Under the Food and Drug Regulations, Canadian drug manufacturers are legally required to report actual and anticipated drug shortages and discontinuations to the official federal website: Drug Shortages Canada (drugshortagescanada.ca) within mandatory timeframes (at least 6 months in advance for anticipated discontinuations, or within 5 calendar days of learning of an unanticipated shortage).
• Tier 3 Drug Shortages: The highest-impact national shortages, where supply and alternatives are insufficient to meet critical medical needs. Tier assignment is made through the national multi-stakeholder process (a Tier Assignment Committee working with Health Canada).

Pharmacy Technician Shortage Mitigation Protocols

1. Active Monitoring: Daily review of backorders against provincial and national shortage ledgers.
2. Allocation Quotas: When wholesalers impose allocation limits (e.g., restricting pharmacies to 50% of historical monthly volume to prevent hoarding), technicians calculate equitable unit-dose rationing.
3. Clinical Conservation: Collaborating with pharmacists to implement therapeutic conservation guidelines (e.g., reserving intravenous pantoprazole exclusively for active GI bleeds while converting stable patients to oral dosage forms).
4. Alternative Sourcing & Compounding: Checking whether a compounded alternative can be prepared safely under NAPRA's non-sterile or sterile compounding standards, and whether Health Canada has authorized an imported product for the shortage (its List of Drugs for Exceptional Importation and Sale). Health Canada's Special Access Program is a separate route that authorizes an unapproved drug for an individual patient at a practitioner's request.